Brian Lortie is the founder of Uniquity Bio. Uniquity Bio has raised $300M in total funding. Latest round: Seed. Backed by Blackstone Life Sciences.
Brian Lortie is a seasoned biopharmaceutical executive who founded Uniquity Bio and currently serves as its Founder, Board Director, and Advisor following his tenure as CEO. He led the company's emergence from stealth in 2024 with $300 million in committed capital from Blackstone Life Sciences to develop a monoclonal antibody program. Uniquity Bio operates under a 'capital-first' strategic model, securing funding before identifying specific assets.
Full founder directory · Investor directory · Company funding database · Fundraising library